Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias
- PMID: 618708
- DOI: 10.1002/cpt197823130
Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias
Abstract
Quinidine in the plasma binds to various lipoproteins as well as to albumin. With the use of computer simulations the effect of varying the serum level of each of the lipoproteins as well as albumin was examined. The results suggested that the overall binding of quinidine is relatively insensitive to changes in any one serum protein provided the others are present in normal concentrations. Evaluation of the degree of protein binding of quinidine in plasma from normal subjects and patients with types IV and IIa hyperlipoproteinemias supported the computer predictions. The degree of protein binding in plasma from normal subjects and patients with types IV and IIA hyperlipoproteinemias were 71.2% +/- 11.4%, 75.9% +/- 8.7%, and 69.9% +/- 15.0%, respectively. The quinidine binding in plasma of patients with hyperlipoproteinemias did not differ statistically from that in the normal subjects.
Similar articles
-
Increased binding of quinidine to serum albumin and lipoproteins in anuric rats.Eur J Pharmacol. 1975 Aug;33(1):131-9. doi: 10.1016/0014-2999(75)90147-8. Eur J Pharmacol. 1975. PMID: 1175679
-
Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma.Biochem Pharmacol. 1977 Feb 1;26(3):229-35. doi: 10.1016/0006-2952(77)90308-2. Biochem Pharmacol. 1977. PMID: 843392 No abstract available.
-
Differences in the binding of quinine and quinidine to plasma proteins.Br J Clin Pharmacol. 1987 Dec;24(6):769-74. doi: 10.1111/j.1365-2125.1987.tb03244.x. Br J Clin Pharmacol. 1987. PMID: 3440096 Free PMC article.
-
Binding of drugs by albumin and plasma protein.J Pharm Sci. 1977 Apr;66(4):447-65. doi: 10.1002/jps.2600660402. J Pharm Sci. 1977. PMID: 323460 Review. No abstract available.
-
Plasma drug binding: implications for anesthesiologists.Anesth Analg. 1986 Jul;65(7):786-804. Anesth Analg. 1986. PMID: 3087239 Review. No abstract available.
Cited by
-
Disease-induced changes in the plasma binding of basic drugs.Clin Pharmacokinet. 1980 May-Jun;5(3):246-62. doi: 10.2165/00003088-198005030-00004. Clin Pharmacokinet. 1980. PMID: 6156048 Review.
-
Clinical pharmacokinetics of quinidine.Clin Pharmacokinet. 1980 Mar-Apr;5(2):150-68. doi: 10.2165/00003088-198005020-00003. Clin Pharmacokinet. 1980. PMID: 6988137 Review.
-
Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.Eur J Drug Metab Pharmacokinet. 1979;4(3):123-7. doi: 10.1007/BF03189413. Eur J Drug Metab Pharmacokinet. 1979. PMID: 393513 Review.
-
Altered quinidine disposition in a patient with chronic active hepatitis.Postgrad Med J. 1982 Feb;58(676):82-4. doi: 10.1136/pgmj.58.676.82. Postgrad Med J. 1982. PMID: 7100030 Free PMC article.
-
Effects of Na+ channel blockers on the restitution of refractory period, conduction time, and excitation wavelength in perfused guinea-pig heart.PLoS One. 2017 Feb 23;12(2):e0172683. doi: 10.1371/journal.pone.0172683. eCollection 2017. PLoS One. 2017. PMID: 28231318 Free PMC article.